Is Breast Milk Stealing The Spotlight Of A Novel Anti-Tumor Compound?


The “magic” of breastmilk is never-ending, plastered everywhere on social media with little regard to true scientific analysis. The idea that breastfeeding prevents cancer is a huge promotion point for why mothers should breastfeed at all costs. But while the cancer-preventing benefits are overblown, there is an even bigger claim surrounding the anti-cancer properties of breastmilk; that breast milk kills cancer, in and of itself.  This is a claim that I have seen made many times, so I decided to dig into the research and see where this claim came from and how truthful the claim is.

So where did this idea that breastmilk can kill cancer cells come from? It’s actually a long, and interesting accident of science.  In 1995 researchers were studying the adherence of bacteria to lung cancer cells in the presence of human milk fractions [1]. Fractionation is simply the process where the different molecule types in any substance are separated from one another. One of the tested fractions showed not only inhibition of bacterial adherence but also induced apoptosis of the tumor cells. Apoptosis is just a fancy word for cell death. This fraction was α-lactalbumin, an abundant protein in milk. However, α-lactalbumin in its natural state has no effect on tumor cells.  So what happened in the 1995 study? It seems that the researchers fractionated the milk at a low pH (acidic) implying that there was some kind of change in the structure of the protein. Further work showed that a reaction between the α-lactalbumin and oleic acid (acids lower pH) form the HAMLET compound [2]. HAMLET stands for Human α-lactalbumin Made LEthal to Tumors. HAMLET is an incredibly interesting compound that induced cell death (apoptosis) in cancer cells but not human cells.

So, does HAMLET really kill cancer? We can look at a 2007 paper that examined HAMLET activity in patients with bladder cancer  [3]. In this study, 9 male patients were treated with intravesical instillation (meaning the HAMLET complex was inserted directly into the bladder through a catheter) every day for 5 days. The results of this study showed that 8 or 9 patients experienced a change in tumor morphology and for all the patients, an increase in shed tumor cells was seen. This is clearly a very small study, but the results are promising, though they are not at all related to breastmilk.  More recent papers consider BAMLET compounds (Bovine α-lactalbumin Made LEthal to Tumors) as an anti-cancer agent [4].  Even though more recent research is interested in BAMLET rather than HAMLET compounds, we don’t see people claiming our 2% milk from the grocery store can kill cancer, because it can’t, and neither can breastmilk.  

So what does all this have to do with breastmilk? The real answer: NOTHING. Not one thing.

On its own human and bovine α-lactalbumin is not useful in the killing of any cells. It’s simply a milk protein that assists in lactose generation. That’s it. Unless this compound is purified and reacted with an acid, oleic acid, in particular, it is 100% useless in the face of cancer. There is the promise for the HAMLET compound in cancer treatment, but breastmilk will only be minimally involved if used at all.


Alexandria Fischer is a Ph.D. candidate at the Rensselaer Polytechnic Institute, studying synthetic microbial communities. She obtained her undergraduate degree at the Colorado School of Mines studying Chemical and Biological Engineering. Alexandria came to know the Fed is Best Foundation when struggling to breastfeed her daughter. There she learned that many of the benefits of breastfeeding are vastly overstated and became a part of the advisory team. As a scientist, she is passionate about communicating science to the general public in an approachable and accurate way. She uses her scientific training to evaluate current infant feeding research for strengths and weaknesses, helping to dispel misinformation commonly circulated in the discourse surrounding breastfeeding.

 [1] Svanborg C, et al. HAMLET kills tumor cells by an apoptosis-like mechanism-cellular, molecular, and therapeutic aspects. Adv. Cancer Res. 2003;88(1–29).

[2] Hakansson,  A., Zhivotovsky, B., Orrenius, S., Sabharwal, H. (1995) Apoptosis induced by a human milk protein. Proc. Natl. Acad. Sci, 92(9064-8068).

[3] Mossberg, A. , Wullt, B. , Gustafsson, L. , Månsson, W. , Ljunggren, E. and Svanborg, C. (2007), Bladder cancers respond to intravesical instillation of (HAMLET human α‐lactalbumin made lethal to tumor cells). Int. J. Cancer, 121: 1352-1359

[4] Rath, E. M., Cheng, Y. Y., Pinese, M., Sarun, K. H., Hudson, A. L., Weir, C., Church, W. B. (2018). BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state. PloS one, 13(8).

Can Stem Cells From Breast Milk Be Found In The Brain Of Babies?

An Evaluation Of The Real Benefits And Risks Of Exclusive Breastfeeding.





One thought on “Is Breast Milk Stealing The Spotlight Of A Novel Anti-Tumor Compound?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.